Determination of galactosamine impurities in heparin sodium using fluorescent labeling and conventional high-performance liquid chromatography
详细信息 查看全文
- 作者：Satsuki Itoh ; Yoko Hiruta ; Noritaka Hashii ; Naho Fujita ; Toru Natsuga ; Toshiaki Hattori ; Aya B ; o ; Yuko Sekimoto ; Kazuyoshi Miyata ; Hiroshi Namekawa ; Kazunori Mabuchi ; Toru Sakai ; Hirotoshi Shimahashi ; Kenzo Kawai ; Hikaru Yoden ; Sadatoshi Koyama ; Susanne Odgaard Herr ; Shunji Natsuka ; Teruhide Yamaguchi ; Nana Kawasaki ; et al.
- 关键词：Heparin sodium ; Limiting test ; Galactosamine ; Dermatan sulfate ; Fluorescent labeling
- 刊名：Biologicals
- 出版年：November, 2013
- 年：2013
- 卷：41
- 期：6
- 页码：355-363
- 全文大小：683 K
文摘
Heparin is a sulfated glycosaminoglycan (GAG), which contains N-acetylated or N-sulfated glucosamine (GlcN). Heparin, which is generally obtained from the healthy porcine intestines, is widely used as an anticoagulant during dialysis and treatments of thrombosis such as disseminated intravascular coagulation. Dermatan sulfate (DS) and chondroitin sulfate (CS), which are galactosamine (GalN)-containing GAGs, are major process-related impurities of heparin products. The varying DS and CS contents between heparin products can be responsible for the different anticoagulant activities of heparin. Therefore, a test to determine the concentrations of GalN-containing GAG is essential to ensure the quality and safety of heparin products. In this study, we developed a method for determination of relative content of GalN from GalN-containing GAG in heparin active pharmaceutical ingredients (APIs). The method validation and collaborative study with heparin manufacturers and suppliers showed that our method has enough specificity, sensitivity, linearity, repeatability, reproducibility, and recovery as the limiting test for GalN from GalN-containing GAGs. We believe that our method will be useful for ensuring quality, efficacy, and safety of pharmaceutical heparins. On July 30, 2010, the GalN limiting test based on our method was adopted in the heparin sodium monograph in the Japanese Pharmacopoeia.